Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2000
11/28/2000CA2172149C Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
11/28/2000CA2164303C Aromatic acetylcholinesterase inhibitors
11/28/2000CA2151820C Structured lipids
11/28/2000CA2085037C Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor compound
11/28/2000CA2068943C 1,3-oxathiolanes useful in the treatment of hepatitis
11/28/2000CA2016500C Process for producing beta-lactamase inhibitor
11/23/2000WO2000070349A1 Identifying material from a breast duct
11/23/2000WO2000070341A2 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
11/23/2000WO2000070099A2 Differential gene expression in specific regions of the brain in neurodegenerative diseases
11/23/2000WO2000070091A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF HUMAN PROTEIN KINASE C-δ EXPRESSION
11/23/2000WO2000070086A1 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms
11/23/2000WO2000070060A1 Production of complex carbohydrates
11/23/2000WO2000070051A1 NEUROPROTECTIVE PROPERTIES OF GDF-15, A NOVEL MEMBER OF THE TGF-β SUPERFAMILY
11/23/2000WO2000070047A2 Full-length molecules expressed in human tissues
11/23/2000WO2000070045A1 Ox2 receptor homologs
11/23/2000WO2000070042A1 143 human secreted proteins
11/23/2000WO2000070036A2 Genes expressed in hippocampus
11/23/2000WO2000070028A1 Sphingosine kinase enzyme
11/23/2000WO2000069917A1 Medicinal compositions for inhibiting kallikrein-kinin system or phospholipase a¿2?
11/23/2000WO2000069895A2 Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins
11/23/2000WO2000069887A2 Rapid dehydration of proteins
11/23/2000WO2000069875A1 C-2 modified erythromycin derivatives
11/23/2000WO2000069874A1 Novel crystalline forms of a macrolide antibiotic
11/23/2000WO2000069868A1 Sulphostin analogues and processes for the preparation of sulphostin and analogues thereof
11/23/2000WO2000069862A2 Hemisynthetic method and intermediates thereof
11/23/2000WO2000069861A1 THIAZOLOPYRIMIDINES USEFUL AS TNFα INHIBITORS
11/23/2000WO2000069860A1 Imidazo-containing heterocyclic compounds, their compositions and uses
11/23/2000WO2000069859A1 Imidazo- and pyrrolo[1,2-a]pyrimid-4-ones as gonadotropin-releasing hormone receptor antagonists
11/23/2000WO2000069858A1 Imidazodiazepine derivative
11/23/2000WO2000069856A1 Compounds and therapeutic methods
11/23/2000WO2000069855A2 Furanone derivatives as inhibitors of cathepsin s
11/23/2000WO2000069848A1 Compounds having cytokine inhibitory activity
11/23/2000WO2000069847A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
11/23/2000WO2000069846A1 4,5,6,7-tetrahydroindazole derivatives as antitumor agents
11/23/2000WO2000069844A1 Oligohydroxyl substituted benzofuran-3-yl and pyridofuranylurea derivatives as phosphodiesterase iv inhibitors
11/23/2000WO2000069842A1 Benzofuranylsulfonates
11/23/2000WO2000069838A1 Ion channel modulating agents
11/23/2000WO2000069836A1 Short-acting benzodiazepines
11/23/2000WO2000069834A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
11/23/2000WO2000069833A1 Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents
11/23/2000WO2000069832A1 Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants
11/23/2000WO2000069831A1 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
11/23/2000WO2000069829A1 Method of inhibiting neurotrophin-receptor binding
11/23/2000WO2000069828A1 Method of inhibiting neurotrophin-receptor binding
11/23/2000WO2000069826A1 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
11/23/2000WO2000069824A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/23/2000WO2000069823A1 Ion channel modulating agents
11/23/2000WO2000069821A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/23/2000WO2000069820A1 Cyclic amine derivatives and their uses
11/23/2000WO2000069819A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors
11/23/2000WO2000069818A1 MORPHOLINO-N-ETHYL ESTER DERIVATIVE OF AN INDOLE sPLA2 INHIBITOR
11/23/2000WO2000069812A1 Novel hydroxamic acid derivatives
11/23/2000WO2000069810A1 Glucagon antagonists/inverse agonists
11/23/2000WO2000069794A2 Use of calcium-activated potassium channel-modulating agents
11/23/2000WO2000069520A2 Use of topical azathioprine to treat inflammatory bowel disorders
11/23/2000WO2000069515A1 Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy
11/23/2000WO2000069472A2 Enzyme-activated anti-tumor prodrug compounds
11/23/2000WO2000069471A1 Enhanced transdermal anesthesia of local anesthetic agents
11/23/2000WO2000069470A2 Improved cellular uptake of bioactive agents
11/23/2000WO2000069469A1 Topical compositions for prostaglandin e1 delivery
11/23/2000WO2000069468A1 Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
11/23/2000WO2000069467A1 Combined method of treatment comprising an aromatase inhibitor and a further biologically active compound
11/23/2000WO2000069466A1 Trapping agent for blood carbonyl compounds
11/23/2000WO2000069465A1 Anticancer agents containing ep1 antagonists as the active ingredient
11/23/2000WO2000069464A1 Novel use
11/23/2000WO2000069460A1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES
11/23/2000WO2000069446A1 Combination therapy for treating hypercholesterolemia
11/23/2000WO2000069445A1 Combination therapy for treating hypercholesterolemia
11/23/2000WO2000069444A1 Glycosaminoglycans having an average molecular weight equal to 2400 d suitable for the treatment of senile dementia
11/23/2000WO2000069442A1 Methods of making and using n-desmethylzopiclone
11/23/2000WO2000069441A1 Compositions and uses of et743 for treating cancer
11/23/2000WO2000069440A2 Nicotine delivery systems
11/23/2000WO2000069439A1 Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction
11/23/2000WO2000069438A1 Pharmaceutical combination of neurokinin receptor antagonist and proton pump inhibitor
11/23/2000WO2000069437A1 Use of agonists or antagonists of the 5-ht7 receptor to treat disorders of the bladder
11/23/2000WO2000069436A1 Methods of using and compositions comprising n-desmethylzolpidem
11/23/2000WO2000069435A1 Il-8 receptor antagonists
11/23/2000WO2000069434A1 Dfmo and celecoxib in combination for cancer chemoprevention and therapy
11/23/2000WO2000069432A1 Remedies or preventives for diseases in association with chemokines
11/23/2000WO2000069431A1 Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response
11/23/2000WO2000069430A1 Novel diphenylethylene compounds
11/23/2000WO2000069429A2 Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
11/23/2000WO2000069428A2 Anionic polymers as toxin binders and antibacterial agents
11/23/2000WO2000069427A1 Composition and method for treating limb ischemia
11/23/2000WO2000069426A2 Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders
11/23/2000WO2000069425A2 Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines
11/23/2000WO2000069424A2 Method of treating psychotic disorders
11/23/2000WO2000069421A2 Transdermal therapeutic system (tts) containing tolterodine
11/23/2000WO2000069417A1 Process for preparing pharmaceutical bulk material having uniform dissolution
11/23/2000WO2000069416A1 Pharmaceutical compositions comprising apocodeine and/or its derivatives
11/23/2000WO2000069415A2 Melt granulation
11/23/2000WO2000069413A1 Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma
11/23/2000WO2000069412A1 Method of treating angina and/or anginal equivalents, and pharmaceutical compositions and kit related thereto
11/23/2000WO2000069408A1 Methods of regulating the condition of mammalian keratinous tissue
11/23/2000WO2000069404A1 Methods for regulating the condition of mammalian keratinous tissue via topical application of phytosterol compositions
11/23/2000WO2000069403A1 Alpha amino acid composition and method for the treatment of skin
11/23/2000WO2000069402A1 Antiperspirant and deodorant compositions containing cyclohexasiloxane
11/23/2000WO2000069390A2 Compositions for improving bioavailability of orally administered drugs
11/23/2000WO2000069277A1 A composition containing carvacrol and thymol for use as a bactericide
11/23/2000WO2000069257A2 Genetic modification of male germ cells for generation of transgenic species and genetic therapies
1 ... 6203 6204 6205 6206 6207 6208 6209 6210 6211 6212 6213 6214 6215 6216 6217 6218 6219 6220 6221 6222 6223 ... 7860